Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-161508

Director sold 99,613 shares at an average $20.35 ($2,027,158)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kersten Dirk · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-15 Sale : show line 1 in the form 10b5-1 −81,840 $20.27 $1,659,044 4,562,546 I
2026-04-16 Sale : show line 2 in the form 10b5-1 −11,116 $21.10 $234,591 4,551,430 I
2026-04-16 Sale : show line 3 in the form 10b5-1 −6,657 $20.06 $133,523 4,544,773 I
Open-market sales · 99,613 sh · avg $20.35 · $2,027,158
Loading xslF345X06/ownership.xml…